Big Names Take Hit on Theranos

Blood-testing company got much of its funding from high-profile private investors who weren ’t part of the ecosystem that typically backs startups and could see their stakes wiped out.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news